Pipeline preview

Surfactant replacement therapy (Surfaxin, Discovery Laboratories) for the prevention of respiratory distress syndrome (RDS) in premature infants

Approvable designations

Priority review

Fast-track designations

Nonapprovable designations

Recommendations against approval